8-13-1　ⓔ文献

  1. 日本循環器学会/日本心不全学会合同ガイドライン：心筋症診療ガイドライン (2018年改訂版)．http://www.j-circ.or.jp/guideline/pdf/JCS2018_tsutsui_kitaoka.pdf

  2. Maron BJ, Towbin JA, et al: Contemporary definitions and classification of the Cardiomyopathies. Circulation, 2006; 113: 1807–1816.

  3. Elliott P, Andersson B, et al: Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 2008; 29: 270–276.

  4. 北畠　顕，友池仁暢編：心筋症－診断の手引きとその解説，かりん舎，2005．

  5. McKenna WJ, Maron BJ, et al: Classification, epidemiology, and global burden of cardiomyopathies. Circ Res, 2017; 121: 722–730.

  6. Japp AG, Gulati A, et al: The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol, 2016; 67: 2996–3010.

  7. McNally EM, Mestroni L: Dilated cardiomyopathy genetic determinants and mechanisms. Circ Res, 2017; 121: 731–748.

  8. Herman DS, Lam L,et al: Truncations of titin causing dilated cardiomyopathy. N Engl J Med, 2012; 366: 619–628.

  9. Tobita T, Nomura S, et al: Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep, 2018; 8: 1998.

  10. Marco D, Anguera I, et al: Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta–analysis. J Am Coll Cardiol HF, 2017; 5: 28–38.

  11. Geske JB, Ommen SR, et al: Hypertrophic cardiomyopathy: clinical update. J Am Coll Cardiol HF, 2018; 6: 364–375.

  12. Maron BJ: Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med, 2018; 379: 655–668.

  13. Kitaoka H, Kubo T, et al: Hypertrophic cardiomyopathy: a heterogeneous and lifelong disease in the real world. Cir J, 2020; 84: 1218–1226.

  14. 難病情報センター：拘束型心筋症．https://www.nanbyou.or.jp/entry/259

  15. 2020年心アミロイドーシス診療ガイドライン．https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2020_Kitaoka.pdf

  16. Muchtar E, Blauwet LA, et al: Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res, 2017; 121: 819–837.

  17. Pereira N, Grogan M, et al: Spectrum of restrictive and infiltrative cardiomyopathies. J Am Coll Cardiol, 2018; 71: 1130–1148.

  18. Marcus FI, McKenna WJ, et al: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J, 2010; 31: 806–814.

  19. Corrado D, Basso C, et al: Arrhythmogenic cardiomyopathy. Circ Res, 2017; 121: 784–802.